Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS clinical trial (Q34626253)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS clinical trial |
scientific article |
Statements
1 reference
Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS clinical trial (English)
1 reference
Kazuma Ohyashiki
1 reference
Yuzuru Kanakura
1 reference
Tsutomu Shichishima
1 reference
Shinichiro Okamoto
1 reference
Kiyoshi Ando
1 reference
Haruhiko Ninomiya
1 reference
Tatsuya Kawaguchi
1 reference
Shinji Nakao
1 reference
Hideki Nakakuma
1 reference
Jun-ichi Nishimura
1 reference
Taroh Kinoshita
1 reference
Camille L Bedrosian
1 reference
Marye Ellen Valentine
1 reference
Gus Khursigara
1 reference
Keiya Ozawa
1 reference
Mitsuhiro Omine
1 reference
12 January 2011
1 reference
1 reference
93
1 reference
1
1 reference
36-46
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference